Our Vision in Action

Wholly-owned programs

inCerebro Drug discovery institute currently has three drug discovery pipelines (September 2021). These three pipelines aim to develop anti-cancer agents, cancer metastasis inhibitors, immunotherapy, and IPF. We aim to release the pre-clinical results of the main pipeline, ICRB-001, this year, and we will continue to add pipelines for the development of first-in-class drugs.

Pipelines Target validation Hit generation Lead identification Lead optimization Pre-clinical development Clinical trials
My Image
ICRB-001
GPCR Anti-Cancer
ICRB-002
IPF Drug Discovery
ICRB-501
Anti-colon Cancer

Collaborative Programs

We currently have over three collaborative programs, including confidential programs.

Collaborator Pipelines etc
My Image
ICRB-501